| Evaluation of cytomegalovirus (CMV)-specific T cell immune reconstitution revealed that baseline antiviral immunity, prophylaxis, or preemptive therapy but not antithymocyte … D Abate, A Saldan, M Fiscon, S Cofano, A Paciolla, L Furian, B Ekser, ... The Journal of infectious diseases 202 (4), 585-594, 2010 | 124 | 2010 |
| Comparison of cytomegalovirus (CMV) enzyme-linked immunosorbent spot and CMV quantiferon gamma interferon-releasing assays in assessing risk of CMV infection in kidney … D Abate, A Saldan, C Mengoli, M Fiscon, C Silvestre, L Fallico, ... Journal of clinical microbiology 51 (8), 2501-2507, 2013 | 113 | 2013 |
| Testing for cytomegalovirus in pregnancy A Saldan, G Forner, C Mengoli, N Gussetti, G Palù, D Abate Journal of clinical microbiology 55 (3), 693-702, 2017 | 83 | 2017 |
| Human cytomegalovirus-specific T-cell immune reconstitution in preemptively treated heart transplant recipients identifies subjects at critical risk for infection D Abate, M Fiscon, A Saldan, S Cofano, C Mengoli, D Sgarabotto, ... Journal of clinical microbiology 50 (6), 1974-1980, 2012 | 71 | 2012 |
| Clinical impact of HSV-1 detection in the lower respiratory tract from hospitalized adult patients C Costa, F Sidoti, A Saldan, F Sinesi, C Balloco, S Simeone, M Lorusso, ... Clinical Microbiology and Infection 18 (8), E305-E307, 2012 | 51 | 2012 |
| Strong cell-mediated immune response to human cytomegalovirus is associated with increased risk of fetal infection in primarily infected pregnant women A Saldan, G Forner, C Mengoli, N Gussetti, G Palù, D Abate Clinical Infectious Diseases 61 (8), 1228-1234, 2015 | 42 | 2015 |
| Diagnostic utility of human cytomegalovirus-specific T-cell response monitoring in predicting viremia in pediatric allogeneic stem-cell transplant patients D Abate, S Cesaro, S Cofano, M Fiscon, A Saldan, S Varotto, C Mengoli, ... Transplantation 93 (5), 536-542, 2012 | 37 | 2012 |
| Cytomegalovirus (CMV) enzyme-linked immunosorbent spot assay but not CMV QuantiFERON assay is a novel biomarker to determine risk of congenital CMV infection in pregnant women G Forner, A Saldan, C Mengoli, N Gussetti, G Palù, D Abate Journal of Clinical Microbiology 54 (8), 2149-2154, 2016 | 29 | 2016 |
| Comparison of the cytomegalovirus (CMV) enzyme-linked immunosorbent spot and CMV QuantiFERON cell-mediated immune assays in CMV-seropositive and-seronegative pregnant and … A Saldan, G Forner, C Mengoli, D Tinto, L Fallico, M Peracchi, N Gussetti, ... Journal of Clinical Microbiology 54 (5), 1352-1356, 2016 | 25 | 2016 |
| Effects of TNF‐Alpha Inhibitors on Circulating T h17 Cells in Patients Affected by Severe Psoriasis S Piaserico, E Sandini, A Saldan, D Abate Drug development research 75, S73-S76, 2014 | 25 | 2014 |
| Optimization of interferon gamma ELISPOT assay to detect human cytomegalovirus specific T-cell responses in solid organ transplants D Abate, A Saldan, G Forner, D Tinto, A Bianchin, G Palù Journal of virological methods 196, 157-162, 2014 | 22 | 2014 |
| The Lack and Cytomegalovirus-Specific Cellular Immune Response May Contribute to the Onset of Organ Infection and Disease in Lung Transplant Recipients C Costa, A Saldan, F Sinesi, F Sidoti, C Balloco, S Simeone, A Piceghello, ... International Journal of Immunopathology and Pharmacology 25 (4), 1003-1009, 2012 | 17 | 2012 |
| Human cytomegalovirus and Epstein–Barr virus infections occurring early after transplantation are risk factors for antibody-mediated rejection in heart transplant recipients A Saldan, C Mengoli, D Sgarabotto, M Fedrigo, A Angelini, G Feltrin, ... Frontiers in Immunology 14, 1171197, 2023 | 5 | 2023 |
| Comparison of CMV ELISPOT and CMV Quantiferon™ interferon-γ releasing assays in assessing risk of CMV infection in kidney transplant recipients. DA Abate, A Saldan, C Mengoli, M Fiscon, C Silvestre, L Fallico, ... Journal of Clinical Microbiology 51 (8), 2501-2507, 2013 | 5 | 2013 |
| CMV-ELISPOT but not CMV-QuantiFERON assay is a novel biomarker to determine the risk of congenital CMV infection in pregnant women G Forner, A Saldan, C Mengoli, N Gussetti, G Palù, D Abate J Clin Microbiol 54 (8), 2149-54, 2016 | 3 | 2016 |
| IL-6–mediated endothelial injury impairs antiviral humoral immunity after bone marrow transplantation P Zhang, P Fleming, CE Andoniou, OG Waltner, SS Bhise, JP Martins, ... The Journal of Clinical Investigation 134 (7), 2024 | 2 | 2024 |
| Early cytomegalovirus reactivation after allogenic bone marrow transplantation is associated with the loss of recipient-derived humoral immunity and is reduced by IL-6 inhibition P Zhang, P Fleming, C Andoniou, JP Martins, A Saldan, R Kuns, ... Blood 138, 648, 2021 | 1 | 2021 |
| Clinical grade multiparametric cell sorting and gene-marking of regulatory T cells AP Ekwe, R Au, P Zhang, BA McEnroe, ML Tan, A Saldan, AS Henden, ... Cytotherapy, 2024 | | 2024 |
| Four-Year Follow-Up of the Maternal Immunological, Virological and Clinical Settings of a 36-Year-Old Woman Experiencing Primary Cytomegalovirus Infection Leading to … G Forner, A Saldan, C Mengoli, S Pizzi, M Fedrigo, N Gussetti, S Visentin, ... Viruses 15 (1), 112, 2022 | | 2022 |
| 424.4: The Protection From CMV Infection in Solid Organ Transplants Is Highly Dependent on CMV T-Cell Specific Immunity And Type of Organ Transplant A Saldan, C Mengoli, D Sgarabotto, M Alessi, A Gambino, L Bonfante, ... Transplantation 106 (9S), S475, 2022 | | 2022 |
